Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 317 - Sulfones; Sulfoxides
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
09/2005
09/01/2005CA2556348A1 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
09/01/2005CA2556270A1 2-substituted and 4-substituted aryl nitrone compouds
09/01/2005CA2535580A1 Methods using fluorosulfones for extinguishing and preventing fire
08/2005
08/31/2005EP1568687A1 Sulphur-containing secondary para-Phenylenediamines, dying composition containing such para-phenylenediamines and methods using this composition and use
08/31/2005EP1567483A1 Improved process for the preparation of 1,3-substituted indenes
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1660799A Retinol compounds
08/31/2005CN1660776A Compound of aroma dihydroxy diamines and preparation method
08/31/2005CN1660766A Ramification of omega oxyacid with lateral chain of chirality methyl
08/31/2005CN1660741A 2-ramification of methyl alkyl diol in optical purity
08/31/2005CN1660720A Method for producing molecular compound
08/31/2005CN1216851C Process for producing bis (4-hydroxy-3-nitriphenyl) compound
08/31/2005CN1216533C Ectoparasitic insect pest controllers for animals and their usage
08/30/2005CA2202879C Calcium receptor-active compounds
08/25/2005WO2005078741A1 Mixture, cation conductor and electrochemical device using those
08/25/2005WO2005077894A1 Modafinil compositions
08/25/2005WO2005077122A2 Compounds and compositions as lxr modulators
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187246 Cell proliferation inhibitors
08/25/2005CA2556106A1 Modafinil compositions
08/25/2005CA2553442A1 Compounds and compositions as lxr modulators
08/24/2005EP1565432A1 Histone deacetylase inhibitors
08/24/2005EP1565431A1 Cannabinoid receptor ligands
08/24/2005EP1565430A1 Biguanide and dihydrotriazine derivatives
08/24/2005EP1565422A1 Vitamin d receptor modulators
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005CN1659154A Method of preparing amine stereoisomers
08/24/2005CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1216036C Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine
08/23/2005US6933319 Resorcinol derivatives
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075417A1 Fluorosulfone compounds
08/18/2005US20050182141 drug abuse, drug addiction; reduce cravings for food or addictive substance such as cocaine, amphetamine, nicotine, opiates, tobacco, alcohol or ecstasy; ketone or hydroxy aryl-cycloalkyl sulfides or S-oxides thereof e.g. 1-(1-(3,4-dichlorophenyl)cyclobutyl)-2-(2-(dimethylamino)ethylthio)ethanone
08/18/2005US20050182139 Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
08/18/2005US20050182096 Haloalkyl containing compounds as cysteine protease inhibitors
08/18/2005US20050182081 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
08/18/2005US20050182060 2-Substituted and 4-substituted aryl nitrone compounds
08/18/2005US20050182040 Benzamide derivatives
08/18/2005CA2536506A1 Fluorosulfone compounds
08/17/2005CN1656064A Preparations of a sulfinyl acetamide
08/17/2005CN1655856A Method for producing specific crystalline modifications of polymorphous substances
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1215057C Process for separating and recovering dimethylsulfoxide from extracted Chinese-medicinal liquid by freeze drying method
08/16/2005US6930208 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005CA2232374C Phenylacetic acid derivatives, processes and intermediates for their preparation, and compositions comprising them
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
08/11/2005WO2005051898A3 Vitamin d receptor modulators
08/11/2005WO2005051888A3 Diphenylamine derivatives
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176994 Simultaneously or continuously reacting a sulfuric ester alkylating agent, an aromatic hydrocarbon preferably containing an electron withdrawing group and an electron donating group, and a maleic anhydride derivative.
08/11/2005US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis
08/11/2005US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders
08/11/2005US20050176815 Malaria therapy
08/11/2005US20050176783 Substituted aromatic-ring compounds, process for producing the same and use
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653030A Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1651408A Amino acid accelerated CuI catalyzed aryl halide and coupling reaction of alkyl sulfonate
08/09/2005US6927309 A clathrate compounds contains triphenyl, or tetrakisphenylthio, or chlorosulfonylphenyl, or tetrakis -4-mercaptophenyl; clathrating other chemical stabilizers, nonvolatal compounds, sustained releaser, pulverizer
08/04/2005WO2005070883A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005WO2005070874A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005WO2005037206A3 Anti-cancer compounds and methods of use thereof
08/04/2005US20050171384 Process for producing dihydroxydiphenyl sulfone
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171209 production of modafinil by reacting benzhydrol, thiourea and hydrobromic acid with a base potassium carbonate salt, then hydrolyzing with poatssium hydroxide and chloroacetamide; useful in treatment of narcolepsy and other sleep disorders; commercial scale
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171148 Aryl and heteroaryl compounds, compositions, methods of use
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/04/2005US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma
08/04/2005CA2554334A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005CA2554333A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005CA2554332A1 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558570A1 Process for purifying and isolating rac-bicalutamide
08/03/2005EP1309535A4 A PROCESS FOR THE PREPARATION OF $g(a)' CHLOROKETONES
08/03/2005CN1649837A Process for producing dihydroxydiphenyl sulfone
08/03/2005CN1649835A Catalytic process for preparing perfluoroethanesulfonyl fluoride and/or perfluorodiethylsulfone
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213020C Phenylalaninol derivatives
08/02/2005US6924391 Antiinflammatory agents; antitumor agent
08/02/2005US6924310 Sulfur compounds such as N-[3,5-dichloro-4-(3-cyclopropylsulfamoyl-4-hydroxy-phenoxy)-phenyl]-malonamic acid, used as anoroexigenic, antiarrhythmia, hypotensive or antidiabetic agents; alopecia
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924304 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2170020C Retroviral protease inhibiting compounds
08/02/2005CA2136167C Method for producing alkylsulfinylbenzamides and 1,2-benzisothiazol-3-ones
07/2005
07/28/2005WO2005068415A1 Phenylalanine derivative
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 159